Research ended
TruBridge, Inc. (TBRG) was acquired by IKS Health for $26.25 a share in cash on 9 July 2026.
Our research on TruBridge, Inc. ended on . Once a takeover closes, the shares stop trading under TBRG and there is nothing left to research. The last note, from , is below.
We keep this page so links to it still work and what we published about the stock stays on the record.
The last thesis
TruBridge has no listed-equity thesis: IKS Health closed its $26.25-per-share cash acquisition on 9 July 2026. The parent's first quarter including TruBridge, reported 5 November 2026, shows revenue up 103.9%, but no standalone TruBridge figures.